Cargando…

Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis

In a phase III study of lansoprazole treatment, patients with healed or unhealed erosive esophagitis entered a titrated open-label treatment period and received lansoprazole for ≤6 years to assess long-term maintenance therapy. Doses were adjusted depending on symptom response. Endoscopy was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovacs, Thomas O., Freston, James W., Haber, Marian M., Hunt, Barbara, Atkinson, Stuart, Peura, David A.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702676/
https://www.ncbi.nlm.nih.gov/pubmed/19267194
http://dx.doi.org/10.1007/s10620-009-0769-5
_version_ 1782168790749937664
author Kovacs, Thomas O.
Freston, James W.
Haber, Marian M.
Hunt, Barbara
Atkinson, Stuart
Peura, David A.
author_facet Kovacs, Thomas O.
Freston, James W.
Haber, Marian M.
Hunt, Barbara
Atkinson, Stuart
Peura, David A.
author_sort Kovacs, Thomas O.
collection PubMed
description In a phase III study of lansoprazole treatment, patients with healed or unhealed erosive esophagitis entered a titrated open-label treatment period and received lansoprazole for ≤6 years to assess long-term maintenance therapy. Doses were adjusted depending on symptom response. Endoscopy was performed yearly. One hundred ninety-five subjects received lansoprazole for <1 to 72 months; most received daily doses of ≤30 mg. Lansoprazole maintained erosive esophagitis remission in 75% of subjects receiving treatment for ≤72 months, with 39 subjects experiencing 50 recurrences. Most subjects (94–95%) had no or mild symptoms of day or night heartburn at study end, and 77% were asymptomatic at first erosive esophagitis recurrence. The most common treatment-related adverse events included diarrhea (10%), headache (8%), and abdominal pain (6%), and were mild or moderate in severity. Long-term lansoprazole is effective and well tolerated when used to maintain erosive esophagitis remission for ≤6 years.
format Text
id pubmed-2702676
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-27026762009-06-29 Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis Kovacs, Thomas O. Freston, James W. Haber, Marian M. Hunt, Barbara Atkinson, Stuart Peura, David A. Dig Dis Sci Original Article In a phase III study of lansoprazole treatment, patients with healed or unhealed erosive esophagitis entered a titrated open-label treatment period and received lansoprazole for ≤6 years to assess long-term maintenance therapy. Doses were adjusted depending on symptom response. Endoscopy was performed yearly. One hundred ninety-five subjects received lansoprazole for <1 to 72 months; most received daily doses of ≤30 mg. Lansoprazole maintained erosive esophagitis remission in 75% of subjects receiving treatment for ≤72 months, with 39 subjects experiencing 50 recurrences. Most subjects (94–95%) had no or mild symptoms of day or night heartburn at study end, and 77% were asymptomatic at first erosive esophagitis recurrence. The most common treatment-related adverse events included diarrhea (10%), headache (8%), and abdominal pain (6%), and were mild or moderate in severity. Long-term lansoprazole is effective and well tolerated when used to maintain erosive esophagitis remission for ≤6 years. Springer US 2009-03-07 2009-08 /pmc/articles/PMC2702676/ /pubmed/19267194 http://dx.doi.org/10.1007/s10620-009-0769-5 Text en © The Author(s) 2009
spellingShingle Original Article
Kovacs, Thomas O.
Freston, James W.
Haber, Marian M.
Hunt, Barbara
Atkinson, Stuart
Peura, David A.
Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title_full Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title_fullStr Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title_full_unstemmed Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title_short Long-Term Efficacy of Lansoprazole in Preventing Relapse of Erosive Reflux Esophagitis
title_sort long-term efficacy of lansoprazole in preventing relapse of erosive reflux esophagitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702676/
https://www.ncbi.nlm.nih.gov/pubmed/19267194
http://dx.doi.org/10.1007/s10620-009-0769-5
work_keys_str_mv AT kovacsthomaso longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis
AT frestonjamesw longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis
AT habermarianm longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis
AT huntbarbara longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis
AT atkinsonstuart longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis
AT peuradavida longtermefficacyoflansoprazoleinpreventingrelapseoferosiverefluxesophagitis